s.girard
TL2 Moderator · Angers
Contributes reviews on supplier material. Based in Angers.
Joined 27 June 2025 · last posted 2d
95 posts, newest first. Showing up to 150.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #57 · Clinical › Prescriber conversations · 26 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pooling trials with different estimands Replied, post #127 · Evidence › Meta-analyses · 25 Jul 2026 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A site rotation scheme that is easy enough to actually follow Replied, post #120 · Practice › Administration · 20 Jul 2026 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The headache that turns out to be dehydration — the long version Replied, post #70 · Nutrition & Training › Hydration & electrolytes · 20 Jul 2026 · 0 likes Worth separating two things that post #66 runs together. Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion.…
-
Programming during a large energy deficit Replied, post #44 · Nutrition & Training › Resistance training · 19 Jul 2026 · 1 like This follows post #41 rather than contradicting it. Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building…
-
Follow-up: UK access routes, dated and sourced Replied, post #13 · Regional › UK & Ireland · 19 Jul 2026 · 0 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
-
Seven-day rolling means and why weekly readings mislead Replied, post #51 · Outcomes › Progress reports · 18 Jul 2026 · 15 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Why side effects reset at each escalation and that is not a failure Replied, post #5 · Practice › Side effects · 12 Jul 2026 · 1 like Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #98 · Evidence › Journal club · 11 Jul 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why the timeline is on the right and not the left — what changed since Replied, post #71 · Meta › Site feedback · 10 Jul 2026 · 0 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #27 · Analytics › Impurities & related substances · 26 Jun 2026 · 22 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #17 · Evidence › Meta-analyses · 19 Jun 2026 · 3 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
What to include when your question involves a chromatogram — one year on Replied, post #23 · Start Here › How to Ask · 2 Jun 2026 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #47 · Wellbeing › Sleep · 31 May 2026 · 5 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Reporting a good result: why nobody bothers and why they should Replied, post #2 · Sourcing › Vendor reports · 7 May 2026 · 3 likes Picking up the opening post: that is the part I would want checked first. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other…
-
Currency conversion and the cost you did not see Replied, post #2 · Sourcing › Payments · 30 Apr 2026 · 0 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
The most useful thing you learned here that was not the answer you came for Replied, post #36 · Lounge › Off topic · 20 Apr 2026 · 10 likes I read post #34 twice before replying, because I had assumed the opposite. Community norms: if you want to discuss how the community should work (not moderation…
-
Preservatives: function, testing, and limits — one year on Replied, post #11 · Pharmacology › Formulation chemistry · 19 Apr 2026 · 0 likes On post #7 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #21 · Analytics › HPLC & UHPLC · 17 Apr 2026 · 0 likes On post #17 — agreed on the reasoning, with one qualification. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #7 · Compounds › Oral incretins · 6 Apr 2026 · 22 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #87 · Practice › Reconstitution · 4 Apr 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #77 · Pharmacology › Pharmacokinetics · 20 Mar 2026 · 0 likes I read post #75 twice before replying, because I had assumed the opposite. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #58 · Lounge › Introductions · 13 Mar 2026 · 0 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #10 · Practice › Dosing & titration · 6 Mar 2026 · 18 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Coming back to: How much context is too much context in a first post? Started this topic · Start Here › How to Ask · 5 Mar 2026 · 28 likes Asking directly, because I could not find a straight answer: How much context is too much context in a first post? Question in the title. Context below, and I have…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #32 · Practice › Administration · 1 Mar 2026 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #114 · Practice › Dosing & titration · 21 Feb 2026 · 22 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Revisiting: Absolute versus relative contraindications Replied, post #16 · Safety › Contraindications · 21 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #26 · Practice › Interactions · 19 Feb 2026 · 1 like Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #39 · Evidence › Study critique · 9 Feb 2026 · 1 like Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
Personal import allowances, compared — a second dataset Replied, post #61 · Access › International · 31 Jan 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Trifluoroacetate content and its consequences Replied, post #45 · Analytics › Impurities & related substances · 29 Jan 2026 · 24 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Guidelines revision: what changed and why — one year on Replied, post #63 · Meta › Announcements · 27 Jan 2026 · 7 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #68 · Pharmacology › Pharmacokinetics · 26 Jan 2026 · 1 like Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Follow-up: Search filters: what is missing Replied, post #16 · Meta › Site feedback · 17 Jan 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #50 · Practice › Storage & stability · 13 Jan 2026 · 14 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #37 · Compounds › Tirzepatide · 10 Jan 2026 · 10 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
A partial dose because the pen emptied mid-injection Replied, post #92 · Practice › Administration · 10 Jan 2026 · 0 likes On post #88 — agreed on the reasoning, with one qualification. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #84 · Compounds › Oral incretins · 9 Jan 2026 · 31 likes Picking up post #81: that is the part I would want checked first. Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #7 · Practice › Side effects · 26 Dec 2025 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #4 · Practice › Storage & stability · 23 Dec 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Container choice matters: the material of the vial, the rubber closure, the fill volume all…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #8 · Research Methods › N-of-1 designs · 5 Dec 2025 · 0 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #22 · Research Methods › N-of-1 designs · 25 Nov 2025 · 21 likes Picking up post #19: that is the part I would want checked first. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias.…
-
Sleep quality changes during weight loss — what changed since Replied, post #63 · Wellbeing › Sleep · 14 Nov 2025 · 12 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #11 · Devices › Pens & autoinjectors · 30 Oct 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #39 · Analytics › Home & field testing · 26 Oct 2025 · 16 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #60 · Compounds › Tirzepatide · 21 Oct 2025 · 20 likes Picking up post #57: that is the part I would want checked first. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea…
-
Sleep tracking data and its considerable limitations Replied, post #40 · Wellbeing › Sleep · 20 Oct 2025 · 0 likes On post #36 — agreed on the reasoning, with one qualification. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to…
-
New subcategory: rationale and scope Replied, post #28 · Meta › Announcements · 15 Oct 2025 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #7 · Safety › Adverse events · 9 Oct 2025 · 28 likes Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #68 · Evidence › Preprints · 1 Oct 2025 · 11 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Reading SURMOUNT-1 without the press release Replied, post #21 · Compounds › Tirzepatide · 30 Sep 2025 · 8 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #101 · Compounds › Oral incretins · 14 Sep 2025 · 8 likes I read post #99 twice before replying, because I had assumed the opposite. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
Payment method and the leverage it gives you, ranked Replied, post #9 · Sourcing › Payments · 14 Sep 2025 · 0 likes Refund policy before ordering: ask what the policy is if you receive damaged material or if the order is incorrect. Get it in writing or screenshot it.
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #41 · Compounds › Repair & healing peptides · 10 Sep 2025 · 22 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
Hypertension improvement and when medication needs revisiting Replied, post #36 · Clinical › Comorbidities · 1 Sep 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Sodium, potassium and magnesium when intake drops Replied, post #59 · Nutrition & Training › Hydration & electrolytes · 15 Jul 2025 · 8 likes Worth separating two things that post #55 runs together. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium…
-
Sequence verification for an obscure compound: how it is done Replied, post #67 · Compounds › Other compounds · 19 Jun 2025 · 2 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #32 · Compounds › Semaglutide · 18 Jun 2025 · 3 likes I read post #30 twice before replying, because I had assumed the opposite. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
-
Coming back to: When "no data" is the complete and final answer Replied, post #10 · Compounds › Other compounds · 10 Jun 2025 · 3 likes post #9 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #22 · Sourcing › Regulatory · 10 Jun 2025 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Regression to the mean in progress reports Replied, post #18 · Research Methods › Statistics · 8 Jun 2025 · 15 likes Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means precise measurement; a wide interval means measurement…
-
Counter-ion content and its effect on measured mass Replied, post #55 · Analytics › Mass spectrometry · 3 Jun 2025 · 2 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
A newcomer's list of things that confused me, and the fixes Replied, post #11 · Start Here › Welcome · 26 May 2025 · 20 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #40 · Regional › UK & Ireland · 25 May 2025 · 0 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Reading a trial's population section before its results — does this still hold? Replied, post #137 · Evidence › Trials · 23 May 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Half-life, steady state, and accumulation worked through Replied, post #12 · Pharmacology › Pharmacokinetics · 22 May 2025 · 17 likes On post #8 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
EU-wide position versus national implementation Replied, post #3 · Regional › European Union · 4 May 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Private prescription with self-payment is legal across the EU and is the…
-
Why "any advice?" is the least effective ending for a post — the long version Started this topic · Start Here › How to Ask · 3 May 2025 · 0 likes Asking directly, because I could not find a straight answer: Why "any advice?" is the least effective ending for a post — the long version Question in the title.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #132 · Evidence › Journal club · 23 Apr 2025 · 11 likes Coming back to post #130, because the follow-up matters more than the original answer. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and…
-
Telehealth prescribing models in the US Replied, post #87 · Regional › North America · 20 Apr 2025 · 0 likes Worth separating two things that post #83 runs together. Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #17 · Evidence › Journal club · 16 Apr 2025 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
[2026 update] Heterogeneity as information rather than as a nuisance Replied, post #2 · Evidence › Meta-analyses · 13 Apr 2025 · 21 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #63 · Compounds › Semaglutide · 3 Apr 2025 · 33 likes Picking up post #60: that is the part I would want checked first. The STEP programme populations were selected: enrollment criteria required baseline body mass index…
-
UK access routes, dated and sourced — a second dataset Replied, post #53 · Regional › UK & Ireland · 21 Mar 2025 · 0 likes On post #49 — agreed on the reasoning, with one qualification. Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #118 · Sourcing › Vendor reports · 18 Mar 2025 · 1 like Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #76 · Evidence › Journal club · 12 Mar 2025 · 29 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Scheduled maintenance and what will be unavailable Replied, post #65 · Meta › Announcements · 7 Mar 2025 · 23 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Criticising the method without criticising the authors Replied, post #44 · Evidence › Study critique · 3 Mar 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Consistent declarations and why they matter more than clever ones Replied, post #70 · Sourcing › Logistics · 22 Feb 2025 · 5 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #127 · Evidence › Journal club · 14 Feb 2025 · 7 likes post #126 answers the question as asked. The question underneath it is different. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #42 · Compounds › Secretagogues & GH axis · 8 Feb 2025 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
What changed in 2026, by region Replied, post #122 · Access › International · 5 Feb 2025 · 7 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #29 · Practice › Reconstitution · 5 Feb 2025 · 12 likes Worth separating two things that post #25 runs together. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all…
-
Body image changing more slowly than the body Replied, post #67 · Wellbeing › Mental health · 18 Dec 2024 · 13 likes Worth separating two things that post #63 runs together. Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #15 · Clinical › Special populations · 20 Nov 2024 · 4 likes This follows post #12 rather than contradicting it. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent…
-
EMA product information as a primary source — does this still hold? Replied, post #67 · Regional › European Union · 16 Nov 2024 · 0 likes Worth separating two things that post #63 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #28 · Access › Insurance & coverage · 15 Nov 2024 · 6 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #27 · Compounds › Semaglutide · 15 Nov 2024 · 6 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #8 · Practice › Dosing & titration · 15 Nov 2024 · 0 likes post #7 answers the question as asked. The question underneath it is different. How the published trials escalated: they used specific step sizes and intervals. The…
-
Why "any advice?" is the least effective ending for a post Replied, post #12 · Start Here › How to Ask · 6 Nov 2024 · 4 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #19 · Compounds › Tirzepatide · 2 Nov 2024 · 4 likes post #18 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Progressive overload when the scale is falling — one year on Replied, post #140 · Nutrition & Training › Resistance training · 9 Oct 2024 · 2 likes post #139 is right about the mechanism and I think understates the practical bit. Maintenance is the goal: preserving lean mass and strength during weight loss is the…
-
Why a preprint's supplementary material is often the best part Replied, post #40 · Evidence › Preprints · 27 Sep 2024 · 8 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Reporting a discrepancy without making an allegation Replied, post #47 · Sourcing › Vendor reports · 28 Aug 2024 · 0 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…